increasing prevalence may increase the demand for treatment of nasal polyps thereby expected
to propel the global nasal polyps treatment market growth.
Global Nasal Polyps Treatment Market Restraints
Side effects associated with the medication used for the treatment of nasal polyps may restrain
the global nasal polyps treatment market growth. The mometasone furoate monohydrate can
cause common side effects such as headache, sore throat, muscle and joint pain, nausea, and in
some cases bleeding of nose. Hence, this factor may obstruct the global nasal polyps treatment
market growth.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/nasal-polyps-treatment-market-2775
Global Nasal Polyps Treatment Market Key Players
Some of the major players operating in the global nasal polyps treatment market include,
Intersect ENT Inc., GlaxoSmithKline Plc, Merck Sharp and Dohme Corp, Teva Branded
Pharmaceutical Products R and D Inc., Norton Waterford Ltd, Sanofi, Regeneron
Pharmaceuticals Inc., Fougera Pharmaceuticals Inc., Glenmark, and Taro Pharmaceuticals
Industries Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702